GT Cure-D Eye/Ear Drops contain Gentamicin (0.3% w/v) and Dexamethasone (0.01% w/v), combining an aminoglycoside antibiotic with a corticosteroid to provide effective treatment for bacterial infections accompanied by inflammation in the eye and ear. Gentamicin exhibits broad-spectrum bactericidal activity against susceptible Gram-negative and some Gram-positive organisms by inhibiting protein synthesis, thereby eliminating the infectious agent. Dexamethasone, a potent anti-inflammatory corticosteroid, reduces swelling, redness, and discomfort by suppressing the inflammatory response. This combination is indicated for the management of bacterial conjunctivitis, keratitis, blepharitis, otitis externa, and other superficial infections where inflammation is significant. The formulation is intended for topical administration, ensuring localized therapeutic effects with minimal systemic absorption. Caution is advised in patients with viral, fungal, or mycobacterial infections, as corticosteroids may exacerbate these conditions. Prolonged use should be avoided to prevent potential adverse effects such as increased intraocular pressure, cataract formation, or secondary infections. GT Cure-D Eye/Ear Drops should be used under medical supervision, with adherence to prescribed dosage and duration to optimize efficacy and minimize risks. Patients should report any worsening symptoms or hypersensitivity reactions promptly.